NeuroPath: Modeling Neural Pathways

• NeuroPath is a unified term that describes computational and statistical frameworks for modeling neural pathways and multi-scale brain functions.
• It integrates methods like topology-weighted ODE models, path signatures, and graph transformers for robust disease prediction and connectome analysis.
• These frameworks achieve improved diagnostic accuracy and interpretability by leveraging sparsity, multi-modal data, and mechanistic insights in neurodegenerative research.

NeuroPath is a conceptually unified term denoting several computational and statistical frameworks developed to model, infer, and interpret neural pathways or path-based mechanisms at multiple scales of brain organization and function. Across the literature, the "NeuroPath" nomenclature subsumes dynamical models of neurodegenerative progression, graph neural architectures for connectome analysis, matrix-valued mediation in imaging-genetics, neuromorphic path planning, and semantic path-finding in knowledge retrieval. All share a pathway-centric interpretation of structure, function, or information flow.

1. Pathway-Centric Dynamical Models in Neurodegeneration

The coupled-mechanisms ("NeuroPath") framework for modeling neurodegenerative progression formalizes both local and network-driven dynamics in disease spread (He et al., 2023). Letting $c_i(t)\in[0,1]$ denote normalized pathology concentration (e.g., tau burden) in region $i$ at time $t$, the evolution follows an ODE with two fundamental components:

• Topology-weighted appearance: Pathology production and aggregation modulated by regional network metrics (e.g., centrality, segregation).
• Connectome-mediated diffusion: Pathology spreads via the graph Laplacian of the individual's white-matter structural connectivity.

The full ODE is: $$\frac{d\mathbf c}{dt} = -k L \mathbf c(t) + \alpha (\mathbf M \mathbf w)\odot \mathbf c(t) \odot [v - \mathbf c(t)]$$ with learned subject-specific rate parameters $(k_i, \alpha_i, t^{\rm onset}_i)$ and a sparse feature-weight vector $\mathbf w$ (Dirichlet+horseshoe prior), capturing the contribution of each network topology metric.

Individual-level Bayesian inference (variational approximation) on ADNI tau-PET data demonstrates substantial improvement over topology-agnostic models (mean $R$ improves from 0.46 to 0.67), yields interpretable mechanistic subtypes (e.g., "structural centrality + segregation"), and robustly identifies patient subgroups with shared disease-driving factors.

2. Path Signatures for Sequential Biomarker Analysis

Path signature methods, here denoted "NeuroPath" in the context of early diagnosis, extract fixed-length, interpretable feature vectors from irregular, multimodal time-series (e.g., longitudinal MRI, cognitive scores). The path signature $S(x)$ comprises iterated integrals of a $d$-dimensional path, capturing both linear and higher-order biomarker interactions (Moore et al., 2018): $$S^I(x) = \int_{0<t_1<\dots<t_k<T} dx_{t_1}^{(i_1)}\cdots dx_{t_k}^{(i_k)}$$ Truncation at level $K$ provides dimensionally controlled, robust representations for downstream classifiers (e.g., logistic L1-regularized regression).

This framework handles missing data, varying visit times, and arbitrary path lengths without imputation, and enables real-time risk monitoring pipelines for Alzheimer's disease by incrementally updating signature features as new measurements arrive.

3. Graph Representation Learning and SC–FC Coupling in Connectomics

The NeuroPath Transformer (Wei et al., 2024) generalizes connectomic representation learning by explicitly modeling the "topological detour": multi-hop pathways in structural connectivity (SC) supporting observed direct (and indirect) functional connectivity (FC) between brain regions. Each subject is encoded as a pair of adjacency matrices $(A^S, A^F)$ with node features $X$; multi-hop detour adjacencies $D^h$ are constructed via: $D^h = \left((\hat A^S)^h > 0\right) \circ \hat A^F$ A dual-branch transformer employs masked multi-head self-attention filtered both by detour masks (TD-MHSA) and by direct FC (FC-MHSA), with a consistency penalty

$$\mathcal{L}_{\rm consist} = \| f_{TD}(X) - f_{FC}(X) \|_F^2$$

to encourage aligned SC–FC representations.

NeuroPath achieves state-of-the-art accuracy in supervised and zero-shot applications (task recognition, disease diagnosis; e.g., ADNI static: 85.6% accuracy vs. 83% best baseline), is robust to parameter choices, and provides mechanistic interpretability by identifying compensatory detour routing in Alzheimer's disease.

4. Matrix-Valued Mediation and Imaging-Genetics

In imaging-genetics, "NeuroPath" denotes a Bayesian mediation framework linking genetic exposure ($z$), whole-brain structural connectivity ($A\in\mathbb{R}^{R\times R}$), and time-to-event outcome ($T$) in survival analysis (Tian et al., 2023). The direct and indirect (mediated via the connectome) effects are parametrized as: $$\begin{aligned} \log T_i &= x_i^\top\beta_x + \sum_{j=1}^J\langle \omega_j \beta_j \beta_j^\top,\, A_i \rangle_F + \beta_z z_i + \epsilon_i\ A_i &= \mathcal{M}\times_3 x_i^\top + \sum_{h=1}^H \eta_h \alpha_h\alpha_h^\top z_i - \operatorname{diag}(G_i) + (E_i-E_i^\top) \end{aligned}$$ with imposed within-graph sparsity, clique-like subgraph selection, and between-graph shrinkage.

Simulations confirm unbiased recovery of mediation effects and subnetworks ($<5\%$ bias, $>95\%$ sensitivity/specificity), while ADNI applications implicate Default-Mode, Limbic, and Somatomotor subnetworks as mediators of APOE $\epsilon4$ risk.

5. Functional Connectivity Path Trajectory Modeling

NeuroPathNet introduces explicit modeling of dynamic inter-community pathway time series ("NeuroPaths") extracted via sliding window FC aggregation over static cortical partitions (Guo et al., 28 Oct 2025). For each partition pair $(C_i, C_j)$, community connection trajectory

$$\operatorname{Path}_{i,j} = \left\{ w_{i,j}^{(1)}, w_{i,j}^{(2)}, ..., w_{i,j}^{(T)} \right\}$$

is embedded and processed by a lightweight temporal Transformer, with a cross-path attention module integrating inter-path information.

Outperforming standard dynamic graph learners (e.g., cGCN, JGAT), NeuroPathNet achieves superior diagnostic accuracy on multiclass ADNI ($66.7\%$ vs $65.0\%$), ABIDE ASD ($79.2\%$ vs $75.7\%$), and mood-disorders cohorts. Interpretability is enhanced via “brain communication fingerprints,” with early-stage disease signatures emerging at the pathway level.

6. Application to Semantic Path Tracking and Retrieval

A separate usage of "NeuroPath" arises in LLM-driven, multi-hop retrieval-augmented generation, inspired by hippocampal place cell path planning (Li et al., 18 Nov 2025). The framework constructs a knowledge graph (KG) of entities and relations, and performs:

• Dynamic path tracking: Iterative semantic path expansion and pruning, guided by goal-directed similarity scoring and LLM prompts.
• Post-retrieval completion: Secondary retrieval using reasoning chains to fill missing links.

Compared to graph-based and iterative RAG baselines, NeuroPath achieves substantial gains in multi-hop QA (e.g., +16.3% recall@2, +13.5% recall@5), reduces LLM token consumption, and is robust across LLM scales and task complexity.

7. Neural and Neuromorphic Path Planning

Originally, "NeuroPath" referred to rapid, parallel path planning by propagating waves of spiking activity in hippocampus-like networks (Ponulak et al., 2012). A wavefront encodes the shortest-path vector field toward a goal via STDP-induced synaptic modifications, enabling agents (or neuromorphic circuitry) to read out the optimal trajectory via spike-driven "bump" dynamics. This approach demonstrates optimal path planning in $\sim$100 ms for $N\sim 2000$ cells and is ideally suited for hardware implementations.

Summary Table: NeuroPath Frameworks

Domain	Core Mechanism	Key Reference
Neurodegeneration modeling	Coupled ODE: topology-weighted growth & diffusion, sparse Bayesian selection	(He et al., 2023)
Sequential biomarker analysis	Path signatures, iterated integrals, sparse logistic regression	(Moore et al., 2018)
Connectome graph learning	SC–FC detour transformer, dual-branch MHSA, consistency loss	(Wei et al., 2024)
Imaging-genetics mediation	Matrix-valued mediation, Bayesian clique subgraph selection	(Tian et al., 2023)
Dynamic FC trajectory	Per-path temporal Transformer, cross-path attention	(Guo et al., 28 Oct 2025)
Semantic retrieval	Goal-driven KG path tracking, LLM reasoning, replay	(Li et al., 18 Nov 2025)
Neural path planning	STDP-induced vector field, bump-following in place cells	(Ponulak et al., 2012)

Concluding Perspective

NeuroPath frameworks converge on the core scientific ambition of explicating the structure, evolution, and function of neural pathways: as generative mechanisms of disease, as mediators of genotype–phenotype relationships, as evolving circuits in task and dysfunction, and as computational primitives in both hardware and cognitive architectures. Across approaches, sparsity, explicit path modeling, and the alignment of multi-modal evidence emerge as consistent themes, enabling robust inference, interpretability, and translational potential.